Co-founder and CEO of 21 Impact Labs and the developer of the soon-to-be-released Xponetiq app for optimizing brain potential. Serial entrepreneur, Co-Founder and CEO/COO of multiple software startups, Brian has successfully raised multiple rounds of VC/PE capital and bought and sold businesses, including the exit of a $340m software startup to a publicly traded company. A passionate advocate for brain health, he is driven by his youngest daughter, who has Down syndrome, to accelerate solutions and cures for Alzheimer’s disease.

Liwaa has over 9 years of experience in the financial industry, as well as with over 7 years of experience in blockchain and cryptocurrency since 2016. He has worked on projects of varying scales and companies ranging from crypto startups to the biggest bank in the UAE, First Abu Dhabi Bank (FAB). Liwaa is a certified blockchain expert with a master's degree in Crypto & Blockchain from the University of Nicosia (UNIC).

Maryna uses neuroimaging, neuropsychological testing, and machine learning to improve early diagnostics of PPA. She works at the Foresight Institute, leading the Neurotech Tree project as they build a new roadmap for the future of neurotechnology. She is also a lecturer at HTW Berlin and the University of Leipzig and Max-Planck Research School, where she teaches an introduction to medicine, with a focus on digital health.

Mark has a background in materials science and wearable sensors and gradually became fascinated with UX and product design with brain-computer interfaces. He is excited with the potential to create new science structures using DeSci and LLMs for a sustainable future. Mark styles himself as an artist-engineer, having broad visions inspiration with an understanding of the engineering tools needed to get stuff done in reality.

Venture Builder, Organization Designer, Startup Accelerator, Mindful Leadership Coach, Alzheimer Parent Caretaker, VC Partner. Yatan have been working for 10+ years on helping early-stage startups get from zero to one and for the last few years has gotten interested in brain health for family reasons and wanted to bring more options that give hope and move the needle to the market.

Heloise is based out of Miami, and comes from an investment background - with experience across VC, M&A, and family offices. She has a degree in Economics and Mathematics from Columbia College, Columbia University. She was also part of the team at Saltwater Capital, handling acquisitions and VC investments for the family office of Uber's first CEO, Ryan Graves.

Katherine is a bicoastal San Francisco/NYC-based scientist, artist, athlete, and neuroscience research professional passionate about uncovering the mysteries of life and making science accessible to all. She has a BA in Cellular Neuroscience and Mathematical Systems Biology from Colgate University. She is continuing her work on neurodegenerative disease modeling and assay development in industry.

Seth Kattapong-Graber is a PhD student in Jean Hébert’s lab at Albert Einstein College of Medicine in the Bronx. He is working on a project to test the proof-of-concept of progressive brain replacement using reverse-engineered iPSC-derived fetal cortical tissue to replace dysfunctional and degenerated adult neocortex. He is currently working to compare hiPSC-derived fetal cortical tissue cells differentiated in culture to primary fetal cortical tissue cells using scRNAseq analysis.